iPSC-derived cardiomyocytes reveal impaired L-type Ca2+ channel function in Brugada syndrome carrying SCN5A mutation
Use comparison of induced pluripotent stem cell-derived cardiomyocytes (iPSC-CMs) derived from symptomatic BrS, asymptomatic mutation carriers (AMCs) and family-matched controls for investigating this variation.